Intravenous Vaccination with BCG Prevents M. tb Infection in Non-Human Primates
Co-hosted by the TB and Vaccine Centres, hear from Dr Robert Seder from the Vaccine Research Center, NIAID, NIH, as he explores the topic “Intravenous Vaccination with BCG Prevents M. tb Infection in Non-Human Primates”.
Dr Robert Seder received his B.A. in Natural Science at Johns Hopkins University in 1981 and his M.D. at Tufts University in 1986, and completed his residency in internal medicine at New York Hospital-Cornell Medical Center. Dr Seder did his postdoctoral training at NIAID with Dr William Paul studying how cytokines influence CD4+ T helper cell differentiation. In 1994, Dr Seder became Chief of the Clinical Immunology Section in the Laboratory of Clinical Investigation, part of the NIAID Division of Intramural Research. Dr Seder was then appointed to a tenured position in the Vaccine Research Center (VRC), Laboratory of Immunology in 2000. Since joining the VRC, Dr Seder has focused his efforts on understanding the innate and adaptive mechanisms by which various vaccines approaches mediate protective antibody and T cell immunity in mouse, non-human primate and human models of HIV, Malaria and Tuberculosis infection. Dr Seder is internationally recognized in the field of vaccine biology and cellular immunology. He currently serves as chief of the Cellular Immunology Section in the VRC.
Please note that this session will NOT be live-streamed/recorded.